Construction and evaluation of the functional polygenic risk score for gastric cancer in a prospective cohort of the European population

被引:0
|
作者
Gu, Yuanliang [1 ,2 ]
Yan, Caiwang [2 ,3 ,4 ]
Wang, Tianpei [2 ]
Hu, Beiping [2 ]
Zhu, Meng [2 ,3 ,4 ,5 ]
Jin, Guangfu [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Southeast Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing 210009, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Dept Epidemiol, Nanjing 211166, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatmen, Nanjing 211166, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Nanjing 211166, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Jiangsu Key Lab Mol & Translat Canc Res,Affiliated, Nanjing 210009, Jiangsu, Peoples R China
[6] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Polygenic risk score; Gastric cancer; Polymorphism; single nucleotide; Cross ancestry; GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; GENETIC RISK; PREDICTION; VARIANTS; ANNOTATION; MUTATIONS; FRAMEWORK;
D O I
10.1097/CM9.0000000000002716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:A polygenic risk score (PRS) derived from 112 single-nucleotide polymorphisms (SNPs) for gastric cancer has been reported in Chinese populations (PRS-112). However, its performance in other populations is unknown. A functional PRS (fPRS) using functional SNPs (fSNPs) may improve the generalizability of the PRS across populations with distinct ethnicities. Methods:We performed functional annotations on SNPs in strong linkage disequilibrium (LD) with the 112 previously reported SNPs to identify fSNPs that affect protein-coding or transcriptional regulation. Subsequently, we constructed an fPRS based on the fSNPs by using the LDpred2-infinitesimal model and then analyzed the performance of the PRS-112 and fPRS in the risk prediction of gastric cancer in 457,521 European participants of the UK Biobank cohort. Finally, the performance of the fPRS in combination with lifestyle factors were evaluated in predicting the risk of gastric cancer. Results:During 4,582,045 person-years of follow-up with a total of 623 incident gastric cancer cases, we found no significant association between the PRS-112 and gastric cancer risk in the European population (hazard ratio [HR] = 1.00 [95% confidence interval (CI) 0.93-1.09], P = 0.846). We identified 125 fSNPs, including seven deleterious protein-coding SNPs and 118 regulatory non-coding SNPs, and used them to construct the fPRS-125. Our result showed that the fPRS-125 was significantly associated with gastric cancer risk (HR = 1.11 [95% CI, 1.03-1.20], P = 0.009). Compared to participants with a low fPRS-125 (bottom quintile), those with a high fPRS-125 (top quintile) had a higher risk of incident gastric cancer (HR = 1.43 [95% CI, 1.12-1.84], P = 0.005). Moreover, we observed that participants with both an unfavorable lifestyle and a high genetic risk had the highest risk of incident gastric cancer (HR = 4.99 [95% CI, 1.55-16.10], P = 0.007) compared to those with both a favorable lifestyle and a low genetic risk. Conclusion:These results indicate that the fPRS-125 derived from fSNPs may act as an indicator to measure the genetic risk of gastric cancer in the European population.
引用
收藏
页码:1671 / 1679
页数:9
相关论文
共 50 条
  • [21] Evaluation of modifiable factors and polygenic risk score in thyroid cancer
    Hoang, Tung
    Quy Nguyen Ngoc
    Lee, Jeonghee
    Lee, Eun Kyung
    Hwangbo, Yul
    Kim, Jeongseon
    ENDOCRINE-RELATED CANCER, 2021, 28 (07) : 481 - 494
  • [22] Utilizing polygenic risk score for breast cancer risk prediction in a Taiwanese population
    Lin, Yi-Hsuan
    Hung, Chih-Chiang
    Lin, Guan-Cheng
    Tsai, I. -Chen
    Lum, Chih Yean
    Hsiao, Tzu-Hung
    CANCER EPIDEMIOLOGY, 2025, 94
  • [23] Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
    Duell, Eric J.
    Travier, Noemie
    Lujan-Barroso, Leila
    Clavel-Chapelon, Francoise
    Boutron-Ruault, Marie-Christine
    Morois, Sophie
    Palli, Domenico
    Krogh, Vittorio
    Panico, Salvatore
    Tumino, Rosario
    Sacerdote, Carlotta
    Ramon Quiros, J.
    Sanchez-Cantalejo, Emilio
    Navarro, Carmen
    Barricarte Gurrea, Aurelio
    Dorronsoro, Miren
    Khaw, Kay-Tee
    Allen, Naomi E.
    Key, Timothy J.
    Bueno-de-Mesquita, H. Bas
    Ros, Martine M.
    Numans, Mattijs E.
    Peeters, Petra H. M.
    Trichopoulou, Antonia
    Naska, Androniki
    Dilis, Vardis
    Teucher, Birgit
    Kaaks, Rudolf
    Boeing, Heiner
    Schuetze, Madlen
    Regner, Sara
    Lindkvist, Bjoern
    Johansson, Ingegerd
    Hallmans, Goran
    Overvad, Kim
    Egeberg, Rikke
    Tjonneland, Anne
    Lund, Eiliv
    Weiderpass, Elisabete
    Braaten, Tonje
    Romieu, Isabelle
    Ferrari, Pietro
    Jenab, Mazda
    Stenling, Roger
    Aune, Dagfinn
    Norat, Teresa
    Riboli, Elio
    Gonzalez, Carlos A.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 94 (05): : 1266 - 1275
  • [24] Combination of phenotype and polygenic risk score in breast cancer risk evaluation in the Spanish population: a case –control study
    J. C. Triviño
    A. Ceba
    E. Rubio-Solsona
    D. Serra
    I. Sanchez-Guiu
    G. Ribas
    R. Rosa
    M. Cabo
    L. Bernad
    G. Pita
    A. Gonzalez-Neira
    G. Legarda
    J. L. Diaz
    A. García-Vigara
    A. Martínez-Aspas
    M. Escrig
    B. Bermejo
    P. Eroles
    J. Ibáñez
    D. Salas
    A. Julve
    A. Cano
    A. Lluch
    R. Miñambres
    J. Benitez
    BMC Cancer, 20
  • [25] Combination of phenotype and polygenic risk score in breast cancer risk evaluation in the Spanish population: a case -control study
    Trivino, J. C.
    Ceba, A.
    Rubio-Solsona, E.
    Serra, D.
    Sanchez-Guiu, I.
    Ribas, G.
    Rosa, R.
    Cabo, M.
    Bernad, L.
    Pita, G.
    Gonzalez-Neira, A.
    Legarda, G.
    Diaz, J. L.
    Garcia-Vigara, A.
    Martinez-Aspas, A.
    Escrig, M.
    Bermejo, B.
    Eroles, P.
    Ibanez, J.
    Salas, D.
    Julve, A.
    Cano, A.
    Lluch, A.
    Minambres, R.
    Benitez, J.
    BMC CANCER, 2020, 20 (01)
  • [26] Polygenic risk score for blood pressure and lifestyle factors with overall and CVD mortality: a prospective cohort study in a Japanese population
    Fujii, Ryosuke
    Hishida, Asahi
    Nakatochi, Masahiro
    Okumiyama, Hiroshi
    Takashima, Naoyuki
    Tsuboi, Yoshiki
    Suzuki, Koji
    Ikezaki, Hiroaki
    Shimanoe, Chisato
    Kato, Yasufumi
    Tamura, Takashi
    Ito, Hidemi
    Michihata, Nobuaki
    Tanoue, Shiroh
    Suzuki, Sadao
    Kuriki, Kiyonori
    Kadota, Aya
    Watanabe, Takeshi
    Momozawa, Yukihide
    Wakai, Kenji
    Matsuo, Keitaro
    HYPERTENSION RESEARCH, 2024, : 2284 - 2294
  • [27] Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
    Levi, Hagai
    Carmi, Shai
    Rosset, Saharon
    Yerushalmi, Rinat
    Zick, Aviad
    Yablonski-Peretz, Tamar
    Wang, Qin
    Bolla, Manjeet K.
    Dennis, Joe
    Michailidou, Kyriaki
    Lush, Michael
    Ahearn, Thomas
    Andrulis, Irene L.
    Anton-Culver, Hoda
    Antoniou, Antonis C.
    Arndt, Volker
    Augustinsson, Annelie
    Auvinen, Paivi
    Freeman, Laura Beane
    Beckmann, Matthias
    Behrens, Sabine
    Bermisheva, Marina
    Bodelon, Clara
    Bogdanova, Natalia V.
    Bojesen, Stig E.
    Brenner, Hermann
    Byers, Helen
    Camp, Nicola
    Castelao, Jose
    Chang-Claude, Jenny
    Chirlaque, Maria-Dolores
    Chung, Wendy
    Clarke, Christine
    Collee, Margriet J.
    Colonna, Sarah
    Couch, Fergus
    Cox, Angela
    Cross, Simon S.
    Czene, Kamila
    Daly, Mary
    Devilee, Peter
    Dork, Thilo
    Dossus, Laure
    Eccles, Diana M.
    Eliassen, A. Heather
    Eriksson, Mikael
    Evans, Gareth
    Fasching, Peter
    Fletcher, Olivia
    Flyger, Henrik
    JOURNAL OF MEDICAL GENETICS, 2023, 60 (12) : 1186 - 1197
  • [28] Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations
    Dai, Juncheng
    Zhu, Meng
    Wang, Yuzhuo
    Qin, Na
    Ma, Hongxia
    He, Yong-Qiao
    Zhang, Ruoxin
    Tan, Wen
    Fan, Jingyi
    Wang, Tianpei
    Zheng, Hong
    Sun, Qi
    Wang, Lijuan
    Huang, Mingtao
    Ge, Zijun
    Yu, Canqing
    Guo, Yu
    Wang, Tong-Min
    Wang, Jie
    Xu, Lin
    Wu, Weibing
    Chen, Liang
    Bian, Zheng
    Walters, Robin
    Millwood, Iona Y.
    Li, Xi-Zhao
    Wang, Xin
    Hung, Rayjean J.
    Christiani, David C.
    Chen, Haiquan
    Wang, Mengyun
    Wang, Cheng
    Jiang, Yue
    Chen, Kexin
    Chen, Zhengming
    Jin, Guangfu
    Wu, Tangchun
    Lin, Dongxin
    Hu, Zhibin
    Amos, Christopher I.
    Wu, Chen
    Wei, Qingyi
    Jia, Wei-Hua
    Li, Liming
    Shen, Hongbing
    LANCET RESPIRATORY MEDICINE, 2019, 7 (10): : 881 - 891
  • [29] Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort
    Stapleton, Caragh P.
    Birdwell, Kelly A.
    McKnight, Amy Jayne
    Maxwell, Alexander P.
    Mark, Patrick B.
    Sanders, M. Lee
    Chapman, Fiona A.
    van Setten, Jessica
    Phelan, Paul J.
    Kennedy, Claire
    Jardine, Alan
    Traynor, Jamie P.
    Keating, Brendan
    Conlon, Peter J.
    Cavalleri, Gianpiero L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (03) : 801 - 810
  • [30] Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
    Lakeman, Inge M. M.
    Rodriguez-Girondo, Mar
    Lee, Andrew
    Ruiter, Rikje
    Stricker, Bruno H.
    Wijnant, Sara R. A.
    Kavousi, Maryam
    Antoniou, Antonis C.
    Schmidt, Marjanka K.
    Uitterlinden, Andre G.
    van Rooij, Jeroen
    Devilee, Peter
    GENETICS IN MEDICINE, 2020, 22 (11) : 1803 - 1811